Concert Pharmaceuticals, Inc. Current Assets
Concert Pharmaceuticals, Inc. had Current Assets of $157.20 million as of 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2022-11-07
- 2022-09-30: Assets, Current $157.20M.
- 2022-06-30: Assets, Current $162.12M.
- 2022-03-31: Assets, Current $114.77M.
- 2021-12-31: Assets, Current $150.33M.
| Period end | Assets, Current |
|---|---|
| 2022-09-30 | $157.20M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $162.12M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $114.77M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $150.33M 10-Q · filed 2022-11-07 |
| 2021-09-30 | $112.91M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $132.98M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $123.86M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $142.72M 10-K · filed 2022-03-03 |
| 2020-09-30 | $136.37M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $154.59M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $169.40M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $116.86M 10-K · filed 2021-02-25 |
| 2019-09-30 | $131.12M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $145.31M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $161.78M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $180.15M 10-K · filed 2020-02-27 |
| 2018-09-30 | $196.06M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $208.99M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $219.46M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $205.73M 10-K · filed 2019-02-28 |
| 2017-09-30 | $209.68M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $106.23M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $86.43M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $97.73M 10-K · filed 2018-03-01 |
| 2016-09-30 | $109.77M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $120.08M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $130.56M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $144.11M 10-K · filed 2017-03-06 |
| 2015-09-30 | $143.36M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $153.40M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $115.64M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $81.72M 10-K · filed 2016-03-01 |
| 2014-09-30 | $93.30M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $100.97M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $110.64M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $34.05M 10-K · filed 2015-03-02 |